NIH Grants 2022
Sep. 27, 2022
Development of a safer stem cell-based diabetes therapy via suicide gene-mediated ablation of proliferative cells.
Evaluation of a beta cell replacement therapy combined product that avoids the need for immunosuppression via localized induction of immune tolerance.
Stay in the loop!
Select your areas of interest to receive industry updates.